Shirley V Wang1, Kristina Stefanini2, Edwin Lewis3, Sophia R Newcomer4, Bruce Fireman5, Matthew F Daley4,6, Jason M Glanz4,7, Jonathan Duffy8, Eric Weintraub8, Martin Kulldorff2. 1. Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, 1620 Tremont Street, Suite 3030, Boston, MA, 02120, USA. swang1@bwh.harvard.edu. 2. Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, 1620 Tremont Street, Suite 3030, Boston, MA, 02120, USA. 3. Kaiser Permanente Vaccine Study Center, Oakland, CA, USA. 4. Institute for Health Research, Kaiser Permanente Colorado, Denver, CO, USA. 5. Kaiser Permanente Division of Research, Oakland, CA, USA. 6. Department of Pediatrics, University of Colorado School of Medicine, Aurora, CO, USA. 7. Colorado School of Public Health, University of Colorado Denver, Aurora, CO, USA. 8. Immunization Safety Office, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Abstract
INTRODUCTION: Childhood immunization schedules often involve multiple vaccinations per visit. When increased risk of an adverse event is observed after simultaneous (same-day) vaccinations, it can be difficult to ascertain which triggered the adverse event. This methods paper discusses a systematic process to determine which of the simultaneously administered vaccine(s) are most likely to have caused an observed increase in risk of an adverse event. METHODS: We use an example from the literature where excess risk of seizure was observed 1 day after vaccination, but same-day vaccination patterns made it difficult to discern which vaccine(s) may trigger the adverse event. We illustrate the systematic identification process using a simulation that retained the observed pattern of simultaneous vaccination in an empirical cohort of vaccinated children. We simulated "true" effects for diphtheria-tetanus-acellular pertussis (DTaP) and pneumococcal conjugate (PCV) on risk of seizure the day after vaccination. We varied the independent and interactive effects of vaccines (on the multiplicative scale). After applying the process to simulated data, we evaluated risk of seizure 1 day after vaccination in the empirical cohort. RESULTS: In all simulations, we were able to determine which vaccines contributed to excess risk. In the empirical data, we narrowed the association with seizure from all vaccines in the schedule to three likely candidates, DTaP, PCV, and/or Haemophilus influenzae type B (HiB) (p < 0.01, attributable risk when all three were administered together: five per 100,000). Disentangling their associations with seizure would require a larger sample or more variation in the combinations administered. When none of these three were administered, no excess risk was observed. CONCLUSION: The process outlined could provide valuable information on the magnitude of potential risk from individual and simultaneousvaccinations. Associations should be further investigated with independent data as well as biologically based, statistically independent hypotheses.
INTRODUCTION: Childhood immunization schedules often involve multiple vaccinations per visit. When increased risk of an adverse event is observed after simultaneous (same-day) vaccinations, it can be difficult to ascertain which triggered the adverse event. This methods paper discusses a systematic process to determine which of the simultaneously administered vaccine(s) are most likely to have caused an observed increase in risk of an adverse event. METHODS: We use an example from the literature where excess risk of seizure was observed 1 day after vaccination, but same-day vaccination patterns made it difficult to discern which vaccine(s) may trigger the adverse event. We illustrate the systematic identification process using a simulation that retained the observed pattern of simultaneous vaccination in an empirical cohort of vaccinated children. We simulated "true" effects for diphtheria-tetanus-acellular pertussis (DTaP) and pneumococcal conjugate (PCV) on risk of seizure the day after vaccination. We varied the independent and interactive effects of vaccines (on the multiplicative scale). After applying the process to simulated data, we evaluated risk of seizure 1 day after vaccination in the empirical cohort. RESULTS: In all simulations, we were able to determine which vaccines contributed to excess risk. In the empirical data, we narrowed the association with seizure from all vaccines in the schedule to three likely candidates, DTaP, PCV, and/or Haemophilus influenzae type B (HiB) (p < 0.01, attributable risk when all three were administered together: five per 100,000). Disentangling their associations with seizure would require a larger sample or more variation in the combinations administered. When none of these three were administered, no excess risk was observed. CONCLUSION: The process outlined could provide valuable information on the magnitude of potential risk from individual and simultaneousvaccinations. Associations should be further investigated with independent data as well as biologically based, statistically independent hypotheses.
Authors: Jonathan Duffy; Eric Weintraub; Simon J Hambidge; Lisa A Jackson; Elyse O Kharbanda; Nicola P Klein; Grace M Lee; S Michael Marcy; Cynthia C Nakasato; Allison Naleway; Saad B Omer; Claudia Vellozzi; Frank DeStefano Journal: Pediatrics Date: 2016-06-06 Impact factor: 7.124
Authors: Robert J Yetman; Julie S Shepard; Anton Duke; Jon E Stek; Maria Petrecz; Stephanie O Klopfer; Barbara J Kuter; Florian P Schödel; Andrew W Lee Journal: Hum Vaccin Immunother Date: 2013-06-06 Impact factor: 3.452
Authors: Irene M Shui; Ping Shi; M Maya Dutta-Linn; Eric S Weintraub; Simon J Hambidge; James D Nordin; Tracy A Lieu Journal: Vaccine Date: 2009-07-17 Impact factor: 3.641
Authors: Michael M McNeil; Julianne Gee; Eric S Weintraub; Edward A Belongia; Grace M Lee; Jason M Glanz; James D Nordin; Nicola P Klein; Roger Baxter; Allison L Naleway; Lisa A Jackson; Saad B Omer; Steven J Jacobsen; Frank DeStefano Journal: Vaccine Date: 2014-08-06 Impact factor: 3.641
Authors: Teresa M Hesley; Keith S Reisinger; Bradley J Sullivan; Erin H Jensen; Susan Stasiorowski; Cathy Meechan; Christina Y Chan; David J West Journal: Pediatr Infect Dis J Date: 2004-03 Impact factor: 2.129
Authors: Scott A Halperin; Bruce Tapiéro; Marc Dionne; William Meekison; Francisco Diaz-Mitoma; Paul Zickler; Earl Rubin; Joanne Embree; Prakash Bhuyan; Andrew Lee; Minran Li; Antigona Tomovici Journal: Pediatr Infect Dis J Date: 2014-01 Impact factor: 2.129